1,944
Views
30
CrossRef citations to date
0
Altmetric
Research Article

Simultaneous targeting therapy for lung metastasis and breast tumor by blocking the NF-κB signaling pathway using Celastrol-loaded micelles

, , , , , , , , & show all
Pages 341-352 | Received 07 Nov 2017, Accepted 05 Jan 2018, Published online: 22 Jan 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Jichao Li, Zeng Zhang & Xiaohan Huang. (2021) Tripterine and all-trans retinoic acid (ATRA) – loaded lipid-polymer hybrid nanoparticles for synergistic anti-arthritic therapy against inflammatory arthritis. Artificial Cells, Nanomedicine, and Biotechnology 49:1, pages 575-585.
Read now
Hailing Yang, Zhenjie Liu, Yonglong Song & Changjiang Hu. (2019) Hyaluronic acid-functionalized bilosomes for targeted delivery of tripterine to inflamed area with enhancive therapy on arthritis. Drug Delivery 26:1, pages 820-830.
Read now

Articles from other publishers (28)

Cheng Wang, Shu Dai, Xingtao Zhao, Yafang Zhang, Lihong Gong, Ke Fu, Cheng Ma, Cheng Peng & Yunxia Li. (2023) Celastrol as an emerging anticancer agent: Current status, challenges and therapeutic strategies. Biomedicine & Pharmacotherapy 163, pages 114882.
Crossref
Xiaoxia Song, Rongrong Zhu, Dandan Guo, Wei Dai & Jianying Liang. (2023) Celastrol Loaded PEGylated Nanographene Oxide for Highly Efficient Synergistic Chemo/Photothermal Therapy. Anti-Cancer Agents in Medicinal Chemistry 23:3, pages 306-316.
Crossref
Na Hui Kim, Minji Kwon, Jiwoo Jung, Hyo Byeong Chae, Jiwoo Lee, Yeo-Jun Yoon, In Seok Moon, Ho K. Lee, Wan Namkung, Konstantina M. Stankovic, Se A. Lee, Jong Dae Lee & Sin-Aye Park. (2022) Celastrol suppresses the growth of vestibular schwannoma in mice by promoting the degradation of β-catenin. Acta Pharmacologica Sinica 43:11, pages 2993-3001.
Crossref
Shaomin Liu, Qiufang Chen, Liang Yan, Yuehong Ren, Jun Fan, Xingwang Zhang & Shiping Zhu. (2022) Phytosomal tripterine with selenium modification attenuates the cytotoxicity and restrains the inflammatory evolution via inhibiting NLRP3 inflammasome activation and pyroptosis. International Immunopharmacology 108, pages 108871.
Crossref
Qingsi Wu, Jiading Wang, Yuanfang Wang, Ling Xiang, Yulu Tan, Jiaxing Feng, Zhirong Zhang & Ling Zhang. (2021) Targeted delivery of celastrol to glomerular endothelium and podocytes for chronic kidney disease treatment. Nano Research 15:4, pages 3556-3568.
Crossref
Zhi Cai, Bin Qian, Jing Pang, Zhou-bin Tan, Kai Zhao & Ting Lei. (2022) Celastrol Induces Apoptosis and Autophagy via the AKT/mTOR Signaling Pathway in the Pituitary ACTH-secreting Adenoma Cells. Current Medical Science 42:2, pages 387-396.
Crossref
Yu Geng, Jiajia Xiang, Shiqun Shao, Jianbin Tang & Youqing Shen. (2022) Mitochondria-targeted polymer-celastrol conjugate with enhanced anticancer efficacy. Journal of Controlled Release 342, pages 122-133.
Crossref
Xiaqing Wu, Xiaoqing Han, Jiao Yan, Runxiao Zheng, Yanjing Wang, Panpan Song & Haiyuan Zhang. (2021) Iron Oxyhydroxide Nanorods Coated with Poly(acrylic acid) to Reprogram Tumor-Associated Macrophages for Antitumor Immunotherapy. ACS Applied Nano Materials 4:12, pages 12966-12976.
Crossref
Jinfeng Shi, Yali Ren, Jiaqi Ma, Xi Luo, Jiaxin Li, Yihan Wu, Huan Gu, Chaomei Fu, Zhixing Cao & Jinming Zhang. (2021) Novel CD44-targeting and pH/redox-dual-stimuli-responsive core–shell nanoparticles loading triptolide combats breast cancer growth and lung metastasis. Journal of Nanobiotechnology 19:1.
Crossref
Ling Guo, Yongping Zhang & Khuloud T. Al-Jamal. (2021) Recent progress in nanotechnology-based drug carriers for celastrol delivery. Biomaterials Science 9:19, pages 6355-6380.
Crossref
Xueqing Zhou, Xuan Liu, Xiqin Yang, Li Wang, Yiling Hong, Keke Lian, Guoxi Qiu, Xuwei Shang, Zhongjun Ma, Hong Yuan & Fuqiang Hu. (2021) Tumor progress intercept by intervening in Caveolin-1 related intercellular communication via ROS-sensitive c-Myc targeting therapy. Biomaterials 275, pages 120958.
Crossref
Yun Qian, Jun Zhang, Rui Xu, Qiang Li, Qi Shen & Guofu Zhu. (2021) Nanoparticles based on polymers modified with pH-sensitive molecular switch and low molecular weight heparin carrying Celastrol and ferrocene for breast cancer treatment. International Journal of Biological Macromolecules 183, pages 2215-2226.
Crossref
Pushkaraj Rajendra Wagh, Preshita Desai, Sunil Prabhu & Jeffrey Wang. (2021) Nanotechnology-Based Celastrol Formulations and Their Therapeutic Applications. Frontiers in Pharmacology 12.
Crossref
Kai Yang, Shushu Yan, Jian Xie, Fang Xie, Zhenzhen Zhao & Keming Zhu. (2021) Sodium houttuyfonate relieves acute lung injury by nano micellar carrier and inhibits mitogen-activated protein kinase and nuclear factor kappa-B activation in mice. Materials Express 11:5, pages 781-788.
Crossref
Yun Lu, Yuan Liu, Jiawei Zhou, Dan Li & Wei Gao. (2020) Biosynthesis, total synthesis, structural modifications, bioactivity, and mechanism of action of the quinone‐methide triterpenoid celastrol. Medicinal Research Reviews 41:2, pages 1022-1060.
Crossref
Jinfeng Shi, Jiaxin Li, Ziyi Xu, Liang Chen, Ruifeng Luo, Chen Zhang, Fei Gao, Jinming Zhang & Chaomei Fu. (2020) Celastrol: A Review of Useful Strategies Overcoming its Limitation in Anticancer Application. Frontiers in Pharmacology 11.
Crossref
Rujing Chen, Leaf Huang & Kaili Hu. (2020) Natural products remodel cancer-associated fibroblasts in desmoplastic tumors. Acta Pharmaceutica Sinica B 10:11, pages 2140-2155.
Crossref
Shuyu Zhan, Amy Paik, Felicia Onyeabor, Baoyue Ding, Sunil Prabhu & Jeffrey Wang. (2020) Oral Bioavailability Evaluation of Celastrol-Encapsulated Silk Fibroin Nanoparticles Using an Optimized LC-MS/MS Method. Molecules 25:15, pages 3422.
Crossref
Aleck Hercbergs, Paul J. Davis, Hung-Yun Lin, Kelly A. Keating & Shaker A. Mousa. 2020. Hormone Therapy and Replacement in Cancer and Aging-related Diseases. Hormone Therapy and Replacement in Cancer and Aging-related Diseases.
Tiantian Huang, Yian Wang, Yiping Shen, Hui Ao, Yifei Guo, Meihua Han & Xiangtao Wang. (2020) Preparation of high drug-loading celastrol nanosuspensions and their anti-breast cancer activities in vitro and in vivo. Scientific Reports 10:1.
Crossref
Lijuan Wen, Kai Wang, Fengtian Zhang, Yanan Tan, Xuwei Shang, Yun Zhu, Xueqing Zhou, Hong Yuan & Fuqiang Hu. (2020) AKT activation by SC79 to transiently re-open pathological blood brain barrier for improved functionalized nanoparticles therapy of glioblastoma. Biomaterials 237, pages 119793.
Crossref
Shiping Zhu, Chunhua Luo, Weifeng Feng, Yan Li, Mujuan Zhu, Shengyun Sun & Xingwang Zhang. (2020) Selenium-deposited tripterine phytosomes ameliorate the antiarthritic efficacy of the phytomedicine via a synergistic sensitization. International Journal of Pharmaceutics 578, pages 119104.
Crossref
Sameh Saber, Amal M. H. Ghanim, Eman El-Ahwany & Eman M. Abd El-Kader. (2020) Novel complementary antitumour effects of celastrol and metformin by targeting IκBκB, apoptosis and NLRP3 inflammasome activation in diethylnitrosamine-induced murine hepatocarcinogenesis. Cancer Chemotherapy and Pharmacology 85:2, pages 331-343.
Crossref
Biqiang Zhu & Yunwei Wei. (2019) Antitumor activity of celastrol by inhibition of proliferation, invasion, and migration in cholangiocarcinoma via PTEN/PI3K/Akt pathway. Cancer Medicine 9:2, pages 783-796.
Crossref
Ming-Yue Yang, Rui-Rui Zhao, Yi-Fan Fang, Jia-Li Jiang, Xiao-Tian Yuan & Jing-Wei Shao. (2019) Carrier-free nanodrug: A novel strategy of cancer diagnosis and synergistic therapy. International Journal of Pharmaceutics 570, pages 118663.
Crossref
Xi Cao, Ying Hu, Shi Luo, Yuejing Wang, Tao Gong, Xun Sun, Yao Fu & Zhirong Zhang. (2019) Neutrophil-mimicking therapeutic nanoparticles for targeted chemotherapy of pancreatic carcinoma. Acta Pharmaceutica Sinica B 9:3, pages 575-589.
Crossref
Xuerong Liu, Cheng Wang, Huisong Ma, Fangying Yu, Fuqiang Hu & Hong Yuan. (2019) Water‐Responsive Hybrid Nanoparticles Codelivering ICG and DOX Effectively Treat Breast Cancer via Hyperthermia‐aided DOX Functionality and Drug Penetration. Advanced Healthcare Materials 8:8, pages 1801486.
Crossref
Jack Prescott & Simon Cook. (2018) Targeting IKKβ in Cancer: Challenges and Opportunities for the Therapeutic Utilisation of IKKβ Inhibitors. Cells 7:9, pages 115.
Crossref